Start for free
Start for free
Fairmount Funds Management logo

Fairmount Funds Management

North America, Pennsylvania, United States, Philadelphia

Description

Fairmount Funds Management is a Philadelphia-based investment firm.

Investor Profile

Fairmount Funds Management has made 25 investments, with 7 in the past 12 months and 28% as lead.

Stage Focus

  • Post Ipo Equity (56%)
  • Series A (24%)
  • Series B (12%)
  • Undisclosed (4%)
  • Series C (4%)

Country Focus

  • United States (88%)
  • United Kingdom (4%)
  • France (4%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Biopharma
  • Pharmaceutical
  • Medical
  • Life Science
  • Health Diagnostics
  • Medical Device
  • Product Research
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Fairmount Funds Management frequently co-invest with?

Wellington Management
Wellington Management
North America, Massachusetts, United States, Boston
Co-Investments: 7
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners
North America, California, United States, Palo Alto
Co-Investments: 16
Braidwell
Braidwell
North America, Connecticut, United States, Stamford
Co-Investments: 6
RTW Investments
RTW Investments
North America, New York, United States, New York
Co-Investments: 7
RA Capital Management
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 6
Deep Track Capital
Deep Track Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 5
Perceptive Advisors
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 10
CC
Commodore Capital
North America, New York, United States, New York
Co-Investments: 7
Logos Capital
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 5
Boxer Capital
Boxer Capital
North America, Florida, United States, Windermere
Co-Investments: 5

Which angels does Fairmount Funds Management often collaborate with?

ME
Martin Edwards
Europe, England, United Kingdom
Shared Deals: 1
AU
Anders Ullman
Europe, Hallands Lan, Sweden, Kungsbacka
Shared Deals: 1
Mark W. Hahn
Mark W. Hahn
North America, North Carolina, United States, Chapel Hill
Shared Deals: 1
VS
Vikas Sinha
North America, Massachusetts, United States, Boston
Shared Deals: 1
David Zaccardelli
David Zaccardelli
North America, United States
Shared Deals: 1
DE
David Ebsworth
Europe, Zurich, Switzerland, Zürich
Shared Deals: 1

What are some of recent deals done by Fairmount Funds Management?

Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines.

BiotechnologyHealth CareMedical Device
UndisclosedOct 29, 2024
Amount Raised: $200,000,000
Inhibikase Therapeutics

Atlanta, Georgia, United States

Inhibikase Therapeutics is a developer of cellular Abelson tyrosine kinase inhibitors to treat infections and other diseases.

Health CareHealth DiagnosticsTherapeutics
Post Ipo EquityOct 9, 2024
Amount Raised: $110,000,000
Candid Therapeutics

San Diego, California, United States

Candid Therapeutics is a biotechnology company that focuses on the treatment of a range of immunological conditions.

BiotechnologyProduct ResearchTherapeutics
Series ASep 9, 2024
Amount Raised: $370,000,000
Oruka Therapeutics

Waltham, Massachusetts, United States

Oruka Therapeutics is advancing innovative biologics to redefine patient care standards in chronic skin diseases.

BiotechnologyHealth CareMedical
Post Ipo EquitySep 3, 2024
Amount Raised: $275,000,000
Jade Biosciences

Waltham, Massachusetts, United States

Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.

Health CareTherapeutics
Series AAug 1, 2024
Amount Raised: $80,000,000
Day One Biopharmaceuticals

South San Francisco, California, United States

Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.

BiopharmaBiotechnologyHealth CarePharmaceutical
Post Ipo EquityJul 30, 2024
Amount Raised: $175,000,000
Zenas BioPharma

Waltham, Massachusetts, United States

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.

BiopharmaHealth CarePharmaceutical
Series CMay 7, 2024
Amount Raised: $200,000,000
Enliven Therapeutics

Boulder, Colorado, United States

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

BiotechnologyLife ScienceOncologyTherapeutics
Post Ipo EquityMar 19, 2024
Amount Raised: $90,000,000
Cogent Biosciences

Waltham, Massachusetts, United States

Cogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors.

BiotechnologyHealth CareMedicalTherapeutics
Post Ipo EquityFeb 13, 2024
Amount Raised: $225,000,000
Dianthus Therapeutics

Waltham, Massachusetts, United States

Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.

BiopharmaBiotechnologyHealth Care
Post Ipo EquityJan 22, 2024
Amount Raised: $230,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator